Recognized standard
E3275-21
FDA recognition 18-20 · ASTM · Nanotechnology
Key facts
| Recognition number | 18-20 |
|---|---|
| Designation | E3275-21 |
| Title | Standard Guide for Visualization and Identification of Nanomaterials in Biological and Nonbiological Matrices Using Darkfield Microscopy/Hyperspectral Imaging (DFM/HSI) Analysis |
| Standards developer | ASTM International |
| Specialty area | Nanotechnology |
| Date of entry | Dec 20, 2021 |
| Scope (excerpt) | 1.1 This guide has been prepared to familiarize laboratory scientists with the background information and technical content necessary to image and identify engineered nanomaterials (ENMs) in cells via darkfield microscopy/hyperspectral imaging(DFM/HSI) methodology. 1.2 DFM/HSI is a hyphenated… |
At a glance
- None Product codes
- 1–9 FDA guidance documents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA-recognized consensus standards
The FDA recognizes voluntary consensus standards that manufacturers can cite in premarket submissions to show conformity with specific requirements.
Source: U.S. Food and Drug Administration (FDA), Recognized Consensus Standards database · Source date: